Camila Franca

Camila Franca is a Research Scientist at the Ragon Institute of Mass General, MIT, and Harvard and a Research Affiliate at the Massachusetts Institute of Technology, involved in developing large-scale platforms for antibody discovery and engineering to enhance vaccine and therapeutic interventions. Previously, Camila served as a Postdoctoral Researcher at Harvard T.H. Chan School of Public Health, focusing on high-throughput serological protocols and the logistics of the first fully remote serological survey during the COVID-19 pandemic. Camila's postdoctoral research experience includes producing human monoclonal antibodies in malaria-endemic areas and optimizing antibody response measurement through a high-throughput Luminex array. Educational qualifications include a PhD in Epidemiology from the University of Melbourne, a Master's in Biotechnology from Universidade Federal de Pernambuco, and a Bachelor's in Biomedicine.